Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC
Article in JTO Clinical and Research Reports (November 2023)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis
Article in BMC Cancer (October 2023)
Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases
Article in Brain Sciences (September 2023)